206 related articles for article (PubMed ID: 25499258)
1. Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis.
Ball MW; Gorin MA; Bhayani SB; Rogers CG; Stifelman MD; Kaouk JH; Zargar H; Marshall S; Larson JA; Rahbar HM; Trock BJ; Pierorazio PM; Allaf ME
Urol Oncol; 2015 Mar; 33(3):112.e9-14. PubMed ID: 25499258
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
[TBL] [Abstract][Full Text] [Related]
3. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
[TBL] [Abstract][Full Text] [Related]
4. Renal pelvic anatomy is associated with incidence, grade, and need for intervention for urine leak following partial nephrectomy.
Tomaszewski JJ; Cung B; Smaldone MC; Mehrazin R; Kutikov A; Viterbo R; Chen DY; Greenberg RE; Uzzo RG
Eur Urol; 2014 Nov; 66(5):949-55. PubMed ID: 24184023
[TBL] [Abstract][Full Text] [Related]
5. Predictors of 30-day acute kidney injury following radical and partial nephrectomy for renal cell carcinoma.
Schmid M; Abd-El-Barr AE; Gandaglia G; Sood A; Olugbade K; Ruhotina N; Sammon JD; Varda B; Chang SL; Kibel AS; Chun FK; Menon M; Fisch M; Trinh QD
Urol Oncol; 2014 Nov; 32(8):1259-66. PubMed ID: 25129142
[TBL] [Abstract][Full Text] [Related]
6. Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.
Oh JJ; Byun SS; Lee SE; Hong SK; Lee ES; Kim HH; Kwak C; Ku JH; Jeong CW; Kim YJ; Kang SH; Hong SH
Int J Urol; 2014 Apr; 21(4):352-7. PubMed ID: 24118633
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
8. Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small renal cortical tumours treated electively.
Broughton GJ; Clark PE; Barocas DA; Cookson MS; Smith JA; Herrell SD; Chang SS
BJU Int; 2012 Jun; 109(11):1607-13. PubMed ID: 21939493
[TBL] [Abstract][Full Text] [Related]
9. Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma.
Zini L; Patard JJ; Capitanio U; Crepel M; de La Taille A; Tostain J; Ficarra V; Bernhard JC; Ferrière JM; Pfister C; Villers A; Montorsi F; Karakiewicz PI
BJU Int; 2009 Apr; 103(7):894-8. PubMed ID: 19076131
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of anatomic and morphologic nomogram to predict malignant and high-grade disease in a cohort of patients with small renal masses.
Bagrodia A; Harrow B; Liu ZW; Olweny EO; Faddegon S; Yin G; Tan YK; Han WK; Lotan Y; Margulis V; Cadeddu JA
Urol Oncol; 2014 Jan; 32(1):37.e17-23. PubMed ID: 23628308
[TBL] [Abstract][Full Text] [Related]
11. Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics.
Jeldres C; Patard JJ; Capitanio U; Perrotte P; Suardi N; Crepel M; Ficarra V; Cindolo L; de La Taille A; Tostain J; Pfister C; Albouy B; Colombel M; Méjean A; Lang H; Jacqmin D; Bernhard JC; Ferrière JM; Bensalah K; Karakiewicz PI
Urology; 2009 Jun; 73(6):1300-5. PubMed ID: 19376568
[TBL] [Abstract][Full Text] [Related]
12. Is there a benefit to frozen section analysis at the time of partial nephrectomy?
Sterious SN; Simhan J; Smaldone MC; Tsai KJ; Canter D; Wameedh E; Li T; Helstrom J; Viterbo R; Chen DY; Greenberg RE; Kutikov A; Al-Saleem T; Uzzo RG
Can J Urol; 2013 Jun; 20(3):6778-84. PubMed ID: 23783047
[TBL] [Abstract][Full Text] [Related]
13. Tumor complexity predicts malignant disease for small renal masses.
Mullins JK; Kaouk JH; Bhayani S; Rogers CG; Stifelman MD; Pierorazio PM; Tanagho YS; Hillyer SP; Kaczmarek BF; Chiu Y; Allaf ME
J Urol; 2012 Dec; 188(6):2072-6. PubMed ID: 23083863
[TBL] [Abstract][Full Text] [Related]
14. Laparoendoscopic single-site partial nephrectomy: a multi-institutional outcome analysis.
Greco F; Autorino R; Rha KH; Derweesh I; Cindolo L; Richstone L; Herrmann TR; Liatsikos E; Sun Y; Fanizza C; Nagele U; Stolzenburg JU; Rais-Bahrami S; Liss MA; Schips L; Kassab A; Wang L; Kallidonis P; Wu Z; Young ST; Mohammed N; Haber GP; Springer C; Fornara P; Kaouk JH
Eur Urol; 2013 Aug; 64(2):314-22. PubMed ID: 23415378
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of benign lesions in renal masses smaller than 7 cm presumed to be renal cell carcinoma.
Akdogan B; Gudeloglu A; Inci K; Gunay LM; Koni A; Ozen H
Clin Genitourin Cancer; 2012 Jun; 10(2):121-5. PubMed ID: 22401753
[TBL] [Abstract][Full Text] [Related]
16. Comparison of diameter-axial-polar nephrometry and RENAL nephrometry score for treatment decision-making in patients with small renal mass.
Naya Y; Kawauchi A; Oishi M; Ueda T; Fujihara A; Naito Y; Nakamura T; Hongo F; Kamoi K; Okihara K; Miki T
Int J Clin Oncol; 2015 Apr; 20(2):358-61. PubMed ID: 24964973
[TBL] [Abstract][Full Text] [Related]
17. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of renal mass biopsy risk stratification algorithm for robotic partial nephrectomy--could a biopsy have guided management?
Rahbar H; Bhayani S; Stifelman M; Kaouk J; Allaf M; Marshall S; Zargar H; Ball MW; Larson J; Rogers C
J Urol; 2014 Nov; 192(5):1337-42. PubMed ID: 24936720
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Trifecta and Pentafecta Outcomes between T1a and T1b Renal Masses following Robot-Assisted Partial Nephrectomy (RAPN) with Minimum One Year Follow Up: Can RAPN for T1b Renal Masses Be Feasible?
Kim DK; Kim LH; Raheem AA; Shin TY; Alabdulaali I; Yoon YE; Han WK; Rha KH
PLoS One; 2016; 11(3):e0151738. PubMed ID: 26987069
[TBL] [Abstract][Full Text] [Related]
20. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
